Cullinan Therapeutics (CGEM) Dividends Paid - Common (2024)
Cullinan Therapeutics' (CGEM) quarterly Dividends Paid - Common came in at $656000.0 in Q3 2024, down 82.7% quarter-over-quarter from $3.8 million in Q2 2024.
Cullinan Therapeutics (CGEM) Dividends Paid - Common (2024) Analysis & Trends
Cullinan Therapeutics' Dividends Paid - Common history runs 1 years deep, the most recent figure standing at $656000.0 for Q3 2024.
- On a quarterly basis, Dividends Paid - Common changed N/A year-over-year to $656000.0 in Q3 2024; TTM through Dec 2025 was $656000.0, a 85.25% decrease from a year earlier, with the FY2024 full-year figure at $4.4 million, changed N/A from the prior year.
- Dividends Paid - Common retreated to $656000.0 in Q3 2024 per CGEM's latest filing, from $3.8 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $3.8 million in Q2 2024 and bottomed at $656000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 97.80 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cullinan Therapeutics | 368.65 Mn | 368.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 656,000.00 |
| Sep 30, 2024 | 656,000.00 |
| Jun 30, 2024 | 3.79 Mn |
| Jun 30, 2024 | 3.79 Mn |